THE WHAT? Church & Dwight has signed a definitive agreement to acquire TheraBreath for US$580 million. The deal is expected to close before the end of the year.
THE DETAILS TheraBreath’s net sales for the trailing 12 months through September 30, 2021 were approximately US$86 million. Currently, international represents less than 10 percent of net sales and Church & Dwight expects to expand distribution through its international footprint.
THE WHY? Matthew T. Farrell, Church & Dwight Chief Executive Officer, explains, “Oral care is important to us strategically. TheraBreath represents a powerful addition to our existing oral care portfolio … The TheraBreath brand is a problem/solution product and one of the fastest growing brands in the mouthwash category. This acquisition gives Church & Dwight a strong position in a growing category with tailwinds as the brand skews towards younger consumers and consistently has a high level of brand loyalty and repeat purchase.”